Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2066-2017Class II

Healon Pro, Part No. 10270012

Advanced Medical Optics, Inc. / initiated 2017-04-01 / Terminated / root cause: manufacturing process

Abbott Medical Optics Inc. (AMO) began a recall of Healon Pro, Part No. 10270012 on . FDA classified it as Class II and gives the reason as "Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2066-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Advanced Medical Optics, Inc.
Product
Healon Pro, Part No. 10270012
Product code
LZP Aid, Surgical, Viscoelastic
Reason for recall
Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
A recall letter was sent to customers on 4/1/17 to inform them that AMO has voluntarily initiated this Action because a remote possibility exists that certain Healon OVD solutions in the affected lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process. Use of OVD solutions with glass particles could potentially lead to intraocular injury. Customers are instructed to complete the Customer Reply Form and fax it to AMO Quality Assurance at 714-247-4510 or email to [email protected] within 3 business days of receipt of the letter. Customers with product complaints or adverse events are instructed to inform AMO by calling 877-266-4543. Customers that do report a complaint are instructed to provide the Healon OVD lot number and, if a patient was involved, the date of surgery, a description of the event and patient outcome.
Quantity in commerce
293,867 units total
Distribution
US and worldwide: Austria Belgium Croatia Czech Republic Denmark Finland France Germany Great Britain Iceland Ireland Israel Italy Latvia Lebanon Lithuania Netherlands Norway Portugal Spain Sweden Switzerland Tunisia Turkey Russian Fed Guadeloupe Sri Lanka Australia China Hong Kong Indonesia Malaysia Singapore South Korea Taiwan Thailand Japan Chile Colombia Costa Rica Ecuador
Product codes and lots
UB32524

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2066-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2062-2017Class IITerminatedVoluntary: Firm initiated
Z-2063-2017Class IITerminatedVoluntary: Firm initiated
Z-2064-2017Class IITerminatedVoluntary: Firm initiated
Z-2065-2017Class IITerminatedVoluntary: Firm initiated
Z-2066-2017Class IITerminatedVoluntary: Firm initiated
Z-2067-2017Class IITerminatedVoluntary: Firm initiated